Skip to main content

ADVERTISEMENT

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD

Clinical Pathways GPS
08/19/2021
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH,...
08/19/2021
Journal of Clinical Pathways
Review
04/13/2020
Rohani Manda, MD
Nader Tavakoli, MD, CMD, FAAFP
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD
Nkenna Odom, MD
Stacy Ross, MD
Tiffany Mapp, MD
The objective of this paper is to emphasize the common vulvovaginal problems, other than infections, in older women and their management.
The objective of this paper is to emphasize the common vulvovaginal problems, other than infections, in older women and their management.
The objective of this paper is...
04/13/2020
Annals of Long-Term Care
Feature
08/17/2017
Nader Tavakoli, MD, CMD, FAAFP
Sidrah Khan, MD
Shelby Knowles, MD
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD
Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...
Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...
...
08/17/2017
Journal of Clinical Pathways